Leprosy post-exposure prophylaxis: innovation and precision public health
Lancet Glob Health
.
2021 Jan;9(1):e8-e9.
doi: 10.1016/S2214-109X(20)30512-X.
Authors
Milton Ozório Moraes
1
,
Nádia Cristina Düppre
2
Affiliations
1
Leprosy Laboratory, Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro 21040-360, Brazil. Electronic address: milton.moraes@fiocruz.br.
2
Leprosy Laboratory, Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro 21040-360, Brazil.
PMID:
33338461
DOI:
10.1016/S2214-109X(20)30512-X
No abstract available
Publication types
Comment
MeSH terms
Feasibility Studies
Humans
Leprosy* / epidemiology
Leprosy* / prevention & control
Post-Exposure Prophylaxis
Public Health
Rifampin*
Substances
Rifampin